Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4517467
Max Phase: Preclinical
Molecular Formula: C31H48FN7O6
Molecular Weight: 633.77
Molecule Type: Unknown
Associated Items:
ID: ALA4517467
Max Phase: Preclinical
Molecular Formula: C31H48FN7O6
Molecular Weight: 633.77
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)CF)C(C)C
Standard InChI: InChI=1S/C31H48FN7O6/c1-19(2)16-23(37-31(44)45-18-21-10-6-5-7-11-21)27(41)38-26(20(3)4)29(43)39-15-9-13-24(39)28(42)36-22(25(40)17-32)12-8-14-35-30(33)34/h5-7,10-11,19-20,22-24,26H,8-9,12-18H2,1-4H3,(H,36,42)(H,37,44)(H,38,41)(H4,33,34,35)/t22-,23-,24-,26-/m0/s1
Standard InChI Key: GMZBJLPXLOYLJY-IGRGDXOOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 633.77 | Molecular Weight (Monoisotopic): 633.3650 | AlogP: 1.75 | #Rotatable Bonds: 17 |
Polar Surface Area: 195.81 | Molecular Species: BASE | HBA: 7 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.17 | CX Basic pKa: 11.77 | CX LogP: 1.50 | CX LogD: -0.53 |
Aromatic Rings: 1 | Heavy Atoms: 45 | QED Weighted: 0.08 | Np Likeness Score: -0.13 |
1. Hatcher JM, Du G, Fontán L, Us I, Qiao Q, Chennamadhavuni S, Shao J, Wu H, Melnick A, Gray NS, Scott DA.. (2019) Peptide-based covalent inhibitors of MALT1 paracaspase., 29 (11): [PMID:30954428] [10.1016/j.bmcl.2019.03.046] |
Source(1):